PMC:7600245 / 230-482
Annnotations
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T1 | 26-40 | Chemical | denotes | pharmaceutical | http://purl.obolibrary.org/obo/CHEBI_52217 |
| T2 | 209-219 | Chemical | denotes | remdesivir | http://purl.obolibrary.org/obo/CHEBI_145994 |
| T3 | 224-237 | Chemical | denotes | dexamethasone | http://purl.obolibrary.org/obo/CHEBI_41879 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T5 | 11-155 | Sentence | denotes | Scientists and pharmaceutical companies have promptly responded by advancing potential therapeutics into clinical trials at an exponential rate. |
| T6 | 156-238 | Sentence | denotes | Initial encouraging results have been realized using remdesivir and dexamethasone. |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 18 | 209-219 | Chemical | denotes | remdesivir | MESH:C000606551 |
| 19 | 224-237 | Chemical | denotes | dexamethasone | MESH:D003907 |